| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| VERACYTE, INC. | President, CLIA U.S. | Stock Option (right to buy) | 103,043 | $2,735,792 | $26.55 | 03 Mar 2022 | Direct |
| VERACYTE, INC. | President, CLIA U.S. | Common Stock | 76,988 | $2,043,262 | $26.54 | 03 Mar 2022 | Direct |
| Azenta, Inc. | Director | Common | 15,772 | $439,250 | $27.85 | 06 Feb 2026 | Direct |
| EXAGEN INC. | Director | Stock Option(right to buy) | 13,500 | $48,330 | $3.58 | 10 Jun 2025 | Direct |
| Aurinia Pharmaceuticals Inc. | Director | Director Stock Option (right to buy) | 63,724 | 16 May 2025 | Direct | ||
| ARENA PHARMACEUTICALS INC | Director | Common Stock | 0 | $98.51 | 11 Mar 2022 | Direct | |
| ARENA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | 11 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AZTA | Azenta, Inc. | 05 Feb 2026 | 1 | +$157,715 | 4 | Director | 06 Feb 2026, 18:12 |
| XGN | EXAGEN INC. | 10 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 17:45 |
| AUPH | Aurinia Pharmaceuticals Inc. | 16 May 2025 | 1 | $0 | 4 | Director | 16 May 2025, 17:06 |
| AUPH | Aurinia Pharmaceuticals Inc. | 15 May 2025 | 0 | $0 | 3 | Director | 16 May 2025, 17:03 |
| AZTA | Azenta, Inc. | 07 Feb 2025 | 1 | +$211,373 | 4 | Director | 11 Feb 2025, 16:10 |
| XGN | EXAGEN INC. | 10 Jun 2024 | 1 | $0 | 4 | Director | 12 Jun 2024, 16:05 |
| AZTA | Azenta, Inc. | 12 Feb 2024 | 1 | -$162,517 | 4 | Director | 13 Feb 2024, 16:10 |
| XGN | EXAGEN INC. | 15 Jun 2023 | 1 | $0 | 4 | Executive Chairperson, Director | 20 Jun 2023, 16:30 |
| AZTA | Azenta, Inc. | 13 Feb 2023 | 1 | $0 | 4 | Director | 15 Feb 2023, 15:18 |
| AZTA | Azenta, Inc. | 03 Feb 2023 | 0 | $0 | 3 | Director | 07 Feb 2023, 15:45 |
| XGN | EXAGEN INC. | 16 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 08:33 |
| /report/000162828022005918-nova-tina-susan-2022-03-11 | ARENA PHARMACEUTICALS INC | 11 Mar 2022 | 8 | $0 | 4 | Director | 11 Mar 2022, 15:24 |
| VCYT | VERACYTE, INC. | 03 Mar 2022 | 2 | $0 | 4 | President, CLIA U.S. | 07 Mar 2022, 15:46 |
| VCYT | VERACYTE, INC. | 02 Mar 2022 | 1 | -$297,749 | 4 | President, CLIA U.S. | 04 Mar 2022, 16:28 |
| VCYT | VERACYTE, INC. | 06 Jan 2022 | 0 | $0 | 3 | President, CLIA U.S. | 13 Jan 2022, 15:47 |
| XGN | EXAGEN INC. | 17 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 08:38 |
| /report/000162828021012279-nova-tina-susan-2021-06-11 | ARENA PHARMACEUTICALS INC | 11 Jun 2021 | 2 | $0 | 4 | Director | 15 Jun 2021, 17:24 |